Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study

Fig. 4

Relative importance of statin therapy duration, statin intensity, and achieved LDL-C levels as predictors for MACE. The relative contributions of statin therapy duration, statin intensity, and achieved LDL-C levels were quantified by calculating the proportion of log-likelihood explained by each risk factor. Other variables in the model included age, sex, socioeconomic status, duration of diabetes, body mass index, fasting blood glucose, systolic blood pressure, creatinine, smoking, alcohol consumption, exercise, pre-existing cardiovascular disease (ischemic heart disease, ischemic stroke, and heart failure), and concurrent medication (anti-thrombotic agents, anti-hypertensive agents by class, and anti-diabetic agents by class). The statin therapy and diabetes durations were included as time-dependent variables

Back to article page